[Metabolic syndrome in dialyzed patients. Advanced glycation end-products, adipocytokines, and principles of treatment].
Metabolic syndrome (MeS) in dialyzed patients, especially in peritoneal dialysis, runs with increased serum concentration of adipocytokines and intensified the process of advanced glycation end-product formation and its consequences. Treatment of MeS in dialyzed patients is as difficult as in general population. Attention was paid for therapeutic aspects, associated with treatment of end-stage renal disease and with dialysis procedure, which may influence the course of MeS.